Use this form to request a free consultation with a qualified attorney near you.
ATTORNEY ADVERTISING -
Your privacy is important to us. Any information submitted to this form is guaranteed safe, secure, and private.
A recent study of an asthma medication called Serevent® indicated that Serevent® side effects may prove lethal for many asthma patients. Asthmatics often rely on daily medication such as Serevent®, a bronchodilator, to ease asthma symptoms. Reports of Serevent® side effects, however, show that users of Serevent® are three times more likely to die of asthma related problems than those who take other asthma medications. Researchers believe that Serevent® side effects can trigger severe asthma attacks, which in some cases prove lethal for the user. Although the FDA has demanded that Serevent® side effects be listed in a black box warning on all product packaging and marketing material, GlaxoSmithKline has yet to comply.
When the FDA originally approved Serevent® for the treatment of asthma, in 1994, the known Serevent® side effects appeared minor in nature. In fact, many drugs had similar issues as the Serevent® side effects that were reported by drug manufacturer GlaxoSmithKline: dry mouth, mild anxiety, muscle cramps, and joint pain. Then, in a study prompted by FDA concerns, 36 patients suffered Serevent® side effects that included several deaths, intubations, and life-threatening asthma attacks. For unknown reasons, African-Americans are at higher risk for Serevent® side effects, as are patients who do not take Serevent® in combination with an anti-inflammatory. A safety monitoring board was so concerned about these reports of Serevent® side effects that the study was shut down, although Serevent® remains on the market. The FDA's requirement of a black box warning regarding Serevent® side effects is the highest level of warning possible on a medication. GlaxoSmithKline's failure to appropriately warn patients and physicians of potential Serevent® side effects could cause them to be held financially liable for any costs associated with Serevent® complications.
Both the FDA and GlaxoSmithKline both insist that Serevent® side effects are outweighed by the potential benefits of the asthma medication, but the fact is that Serevent® side effects have been proven to kill users. If you or a loved one is currently using Serevent® for the treatment of asthma or chronic obstructive pulmonary disease, discuss potential Serevent® side effects with your physician. You should not reduce or cease your use of Serevent® unless so advised by a doctor. Persons who have suffered injury due to Serevent® side effects may be entitled to recover funds associated with the injury such as medical costs, lost wages, and pain and suffering. If you believe that a loved one died as the result of Serevent® side effects, the family may be eligible to receive compensation related to that death. An attorney who has represented victims of Serevent® side effects will be able to help you make critical legal decisions to protect yourself and your loved ones.
For more information on Serevent® side effects and your legal rights, please contact us.
More Serevent® Resources
American Academy of Asthma, Allergy, and Immunology - Resources and research funding information about those disorders.
MedWatch - Important safety information regarding Serevent and related side effects.